Orchard Therapeutics plc Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Orchard Therapeutics plc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q1 2020 to Q1 2023.
  • Orchard Therapeutics plc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2023 was $812K, a 39.8% increase year-over-year.
  • Orchard Therapeutics plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $2.65M, a 25.9% increase from 2021.
  • Orchard Therapeutics plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $2.1M, a 15% increase from 2020.
  • Orchard Therapeutics plc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $1.83M, a 49% increase from 2019.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $812K +$231K +39.8% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $581K +$99K +20.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $482K -$3K -0.62% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $485K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.